BioPlus Co. Ltd. (099430) Price & Analysis

― Followers

099430 Stock Chart & Stats

$3525.00

$215.00(6.50%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range$3,065.00 - $7,350.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩198.64B

Enterprise Value$395.84K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)14.3

Beta0.36

Next Earnings

Aug 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)109.12

Shares Outstanding61,640,720

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

099430 FAQ

What was BioPlus Co. Ltd.’s price range in the past 12 months?

BioPlus Co. Ltd. lowest stock price was $3065.00 and its highest was $7350.00 in the past 12 months.

What is BioPlus Co. Ltd.’s market cap?

BioPlus Co. Ltd.’s market cap is ₩198.64B.

When is BioPlus Co. Ltd.’s upcoming earnings report date?

BioPlus Co. Ltd.’s upcoming earnings report date is Aug 19, 2026 which is in 17 days.

How were BioPlus Co. Ltd.’s earnings last quarter?

BioPlus Co. Ltd. released its earnings results on May 14, 2026. The company reported $109.122 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is BioPlus Co. Ltd. overvalued?

According to Wall Street analysts BioPlus Co. Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does BioPlus Co. Ltd. pay dividends?

BioPlus Co. Ltd. does not currently pay dividends.

What is BioPlus Co. Ltd.’s EPS estimate?

BioPlus Co. Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does BioPlus Co. Ltd. have?

BioPlus Co. Ltd. has 61,640,720 shares outstanding.

What happened to BioPlus Co. Ltd.’s price movement after its last earnings report?

BioPlus Co. Ltd. reported an EPS of $109.122 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.309%.

Which hedge fund is a major shareholder of BioPlus Co. Ltd.?

Currently, no hedge funds are holding shares in KR:099430

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology